readthroughSign in
CompanyIRDNasdaqDurham, NC

Ocuphire Pharma, Inc.

Opus Genetics develops AAV gene therapies for inherited retinal diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story